Robert J Motzer Selected Research

Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)

1/2021	Four Cycles of Etoposide plus Cisplatin for Patients with Good-Risk Advanced Germ Cell Tumors.
1/2020	Adjuvant Chemotherapy With Etoposide Plus Cisplatin for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumors.
1/2019	Surgical Management of Patients with Advanced Germ Cell Tumors Following Salvage Chemotherapy: Memorial Sloan Kettering Cancer Center (MSKCC) Experience.
1/2017	Clinical Outcome of Patients with Fibrosis/Necrosis at Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Advanced Germ Cell Tumors.
9/2016	Pelvic Lymph Node Dissection in Patients Treated for Testis Cancer: The Memorial Sloan Kettering Cancer Center Experience.
1/2016	Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients With Intermediate- or Poor-Risk Germ Cell Tumors.
10/2015	Phase I/II Trial of Paclitaxel With Ifosfamide Followed by High-Dose Paclitaxel, Ifosfamide, and Carboplatin (TI-TIC) With Autologous Stem Cell Reinfusion for Salvage Treatment of Germ Cell Tumors.
2/2015	Rates of teratoma and viable cancer at post-chemotherapy retroperitoneal lymph node dissection after induction chemotherapy for good risk nonseminomatous germ cell tumors.
8/2013	A phase 2 multicenter study of tivantinib (ARQ 197) monotherapy in patients with relapsed or refractory germ cell tumors.
7/2013	Clinical features, presentation, and tolerance of platinum-based chemotherapy in germ cell tumor patients 50 years of age and older.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert J Motzer Research Topics

Disease

227	Renal Cell Carcinoma (Grawitz Tumor) 10/2022 - 01/2002
118	Neoplasms (Cancer) 02/2022 - 01/2002
38	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2021 - 11/2002
24	Fatigue 10/2020 - 01/2007
21	Disease Progression 09/2021 - 01/2002
18	Hypertension (High Blood Pressure) 01/2022 - 11/2007
18	Neoplasm Metastasis (Metastasis) 12/2018 - 11/2003
16	Kidney Neoplasms (Kidney Cancer) 01/2022 - 08/2004
14	Teratoma (Teratoid Tumor) 10/2019 - 10/2003
11	Testicular Neoplasms (Testicular Cancer) 09/2016 - 11/2003
8	Hypoxia (Hypoxemia) 02/2018 - 12/2006
7	Exanthema (Rash) 10/2019 - 05/2007
7	Diarrhea 10/2018 - 01/2007
5	Stomatitis 01/2020 - 09/2007
5	Nonseminomatous germ cell tumor 08/2018 - 02/2004
5	Hand-Foot Syndrome 12/2015 - 10/2008
4	Dyspnea (Shortness of Breath) 10/2018 - 06/2008
4	Hyperglycemia 10/2016 - 05/2007
4	Thrombocytopenia (Thrombopenia) 10/2016 - 01/2009
4	Neutropenia 12/2015 - 06/2006
3	Tics (Tic) 01/2021 - 10/2015
3	Fibrosis (Cirrhosis) 01/2019 - 01/2002
3	Body Weight (Weight, Body) 01/2019 - 11/2015
3	Anemia 07/2017 - 06/2006
3	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2017 - 07/2010
3	Embryonal Carcinoma 01/2017 - 10/2003
3	Edema (Dropsy) 12/2015 - 05/2007
3	Asthenia 12/2015 - 05/2007
3	Carcinoma (Carcinomatosis) 02/2015 - 01/2011
3	Clear-cell metastatic renal cell carcinoma 03/2014 - 05/2013
3	Pneumonia (Pneumonitis) 08/2013 - 08/2008
3	Seminoma 11/2003 - 01/2002
2	Inflammation (Inflammations) 10/2022 - 01/2022
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2019
2	Endometrial Neoplasms (Endometrial Cancer) 01/2022 - 10/2020
2	Carcinogenesis 01/2019 - 03/2008
2	Nausea 10/2018 - 09/2007
2	Necrosis 01/2017 - 07/2011
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2017 - 03/2011

Drug/Important Bio-Agent (IBA)

101	Sunitinib (Sutent)FDA Link 10/2022 - 01/2006
47	Everolimus FDA Link 01/2022 - 12/2006
37	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2022 - 08/2005
31	NivolumabIBA 01/2022 - 05/2015
29	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2002
20	Immune Checkpoint InhibitorsIBA 10/2022 - 09/2016
19	Tyrosine Kinase InhibitorsIBA 01/2022 - 05/2006
19	Interferon-alpha (Interferon Alfa)IBA 08/2014 - 01/2002
17	Bevacizumab (Avastin)FDA Link 02/2022 - 12/2006
16	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 10/2022 - 01/2006
16	Axitinib (AG 013736)IBA 10/2022 - 11/2007
15	cabozantinibIBA 01/2022 - 11/2015
15	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2002
14	pazopanib FDA Link 01/2021 - 08/2013
13	IpilimumabIBA 01/2022 - 04/2018
13	TOR Serine-Threonine KinasesIBA 01/2019 - 09/2007
12	Etoposide (VP 16)FDA LinkGeneric 01/2021 - 01/2002
12	Sorafenib (BAY 43-9006)FDA Link 08/2015 - 12/2006
11	Pharmaceutical PreparationsIBA 01/2021 - 09/2004
10	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 12/2010
10	InterferonsIBA 02/2016 - 04/2007
9	lenvatinibIBA 01/2022 - 11/2015
9	CytokinesIBA 01/2018 - 09/2004
8	atezolizumabIBA 02/2022 - 01/2018
8	temsirolimus FDA Link 10/2014 - 12/2006
7	Biological ProductsIBA 01/2022 - 01/2002
6	Proteins (Proteins, Gene)FDA Link 01/2019 - 07/2007
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2016 - 09/2005
5	B7-H1 AntigenIBA 01/2022 - 01/2019
5	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021 - 01/2002
5	PlatinumIBA 10/2019 - 01/2002
5	Ifosfamide FDA LinkGeneric 01/2016 - 09/2005
5	MTOR InhibitorsIBA 04/2014 - 08/2010
4	avelumabIBA 10/2022 - 01/2019
4	LigandsIBA 02/2022 - 03/2016
4	pembrolizumabIBA 01/2021 - 03/2019
4	Hemoglobins (Hemoglobin)IBA 06/2017 - 10/2006
4	Tumor Biomarkers (Tumor Markers)IBA 10/2014 - 10/2007
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2013 - 01/2006
3	RNA (Ribonucleic Acid)IBA 01/2022 - 12/2010
3	Lipase (Acid Lipase)FDA Link 10/2019 - 06/2006
3	Interleukin-2 (IL2)IBA 12/2017 - 08/2008
3	Imatinib Mesylate (Gleevec)FDA Link 01/2017 - 05/2006
3	Carboplatin (JM8)FDA LinkGeneric 10/2015 - 01/2007
3	Alkaline PhosphataseIBA 01/2015 - 10/2006
3	Carbonic Anhydrase IXIBA 10/2014 - 04/2007
2	MicroRNAs (MicroRNA)IBA 06/2020 - 12/2010
2	Amylases FDA Link 10/2019 - 12/2015
2	Alanine Transaminase (SGPT)IBA 10/2019 - 08/2013
2	NucleotidesIBA 01/2019 - 02/2016
2	Phosphotransferases (Kinase)IBA 10/2018 - 05/2006

Therapy/Procedure

127	Therapeutics 10/2022 - 01/2002
40	Drug Therapy (Chemotherapy) 01/2021 - 01/2002
27	Nephrectomy 01/2022 - 12/2002
23	Lymph Node Excision (Lymph Node Dissection) 01/2020 - 11/2002
10	Immunotherapy 01/2022 - 01/2016
6	Aftercare (After-Treatment) 01/2021 - 06/2003
6	Adjuvant Chemotherapy 01/2020 - 11/2002
4	Salvage Therapy 02/2016 - 01/2007
3	Drug Tapering 03/2015 - 08/2010
3	Radiotherapy 02/2015 - 11/2003